Our Corporate Members
Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 113,000 colleagues serve people in more than 160 countries.
Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews
Medtronic
Making healthcare better is our priority and we believe technology can play an even greater role in improving people’s lives. In addition to alleviating pain, restoring health, extending lives, we work in partnership with others to create seamless, more efficient care. Learn how we’re taking healthcare Further, Together at Medtronic.com.
Microlife
Omron
By looking beyond the technology, our real commitment lies in building healthy lives. We aim to provide a total healthcare management service, aimed at preventing and improving such increasingly common health problems as hypertension, respiratory problems, diabetes and obesity.
Servier
Founded to serve health, Servier is a global pharmaceutical group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. The 21,400 employees of the Group are committed to this shared vocation, a source of inspiration every day.
find out more
As a world leader in cardiology, Servier’s ambition is to become a renowned, focused and innovative player in oncology by targeting difficult and hard-to-treat cancers. That is why the Group allocates over 50% of its R&D budget to Oncology.
Neuroscience and immuno-inflammatory diseases are the future growth drivers. In these areas, Servier is focused on a limited number of diseases in which accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine.
To promote access to quality care for all at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, relying on strong brands in France, Eastern Europe, Brazil and Nigeria.
In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine.
Headquartered in France, Servier relies on a strong geographical footprint in over 150 countries and achieved a revenue of €4.9 billion in 2022. More information on the new Group website: servier.com Follow us on social media: LinkedIn, Facebook, Twitter, Instagram
Our group commitment is to continuously ensure the quality of our medicines, the monitoring of side effects linked to their use as well as safety risks for patients in case of misuse, medication errors and non-Market Authorization (MA) uses. If you think you may have a health problem related to a Servier product, you can contact us at any time and report it to us by filling out the form in the following webpage: https://servier.com/en/contact/report-a-side-effect/
Contact:
+33 (0)1 55 72 60 00 / contact@servier.com
Servier: Suresnes, France
50 rue Carnot – 92284 Suresnes cedex – France
Companies wishing to become Corporate Members of the ISH should contact the Secretariat for further details >> secretariat@ish-world.com
;
